基于风险评分的临床试验高效亚组开发与检验方法
针对临床试验中仅部分患者获益的情况,提出交叉验证风险评分(CVRS)设计方法,无需选择调优参数,基于风险评分和非参数聚类划分敏感组。模拟和真实精神病学试验显示,CVRS较自适应特征设计(ASD)大幅减少计算时间,并在多个场景下提高正确识别敏感组的能力和检测治疗效应的功效。
要点
- CVRS设计无需选择调优参数,降低计算成本。
- 模拟显示CVRS在识别敏感组和检测治疗效应上优于ASD。
- 方法在精神病学试验中展示了应用可行性。
核心结论
- CVRS设计无需调优参数,计算时间显著减少,并在多个模拟场景下提高识别敏感组的能力和检测治疗效应的功效。
研究设计与样本
- 方法学研究,提出CVRS设计,通过模拟数据和一项真实精神病学试验与交叉验证ASD比较。
主要发现
- CVRS在不同样本量和响应率下大幅减少计算时间。
- 许多模拟场景中,CVRS正确识别敏感组的能力和检测敏感组治疗效应的功效显著改善。
临床怎么用
- 可用于临床试验中基于高维信息开发高效患者亚组并检验治疗效应。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
There is the potential for high-dimensional information about patients collected in clinical trials (such as genomic, imaging, and data from wearable technologies) to be informative for the efficacy of a new treatment in situations where only a subset of patients benefits from the treatment. The adaptive signature design (ASD) method has been proposed for developing and testing the efficacy of a treatment in a high-efficacy patient group (the sensitive group) using genetic data. The method requires selection of three tuning parameters which may be highly computationally expensive. We propose a variation to the ASD method, the cross-validated risk scores (CVRS) design method, that does not require selection of any tuning parameters. The method is based on computing a risk score for each patient and dividing them into clusters using a nonparametric clustering procedure. We assess the properties of CVRS against the originally proposed cross-validated ASD using simulation data and a real psychiatry trial. CVRS, as assessed for various sample sizes and response rates, has a substantial reduction in the computational time required. In many simulation scenarios, there is a substantial improvement in the ability to correctly identify the sensitive group and the power of the design to detect a treatment effect in the sensitive group. We illustrate the application of the CVRS method on the psychiatry trial.
引用
- Cherlin S, Wason JMS. Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores. Stat Med. 2020. PMID: 32662542. doi:10.1002/sim.8665
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。